Image

Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Non Recruiting
18-90 years
All
Phase N/A

Powered by AI

Overview

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Description

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.

Eligibility

Inclusion Criteria:

  • Patient cohort :
  • men and women over 18 years of age
  • Informed volunteers who have consented to participate in the study
  • have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
  • have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
  • Cohort of referring physicians :
  • volunteers who received informed information and consented to participate in the study
  • be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes

Exclusion Criteria:

  • Patient cohort :
  • psychiatric pathologies or history of behavioural disorders
  • persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
  • persons under guardianship or curatorship
  • not affiliated to the social security system
  • minors
  • Refusal to participate by the patient and/or unreturned questionnaire
  • Cohort of referring physicians:
  • the physician is no longer the patient's referring physician
  • refusal of the doctor to participate and/or questionnaire not returned

Study details
    Chronic Inflammatory Disease

NCT05613712

University Hospital, Grenoble

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.